New research presented at ESCMID Global 2025 reveals that S. haematobium, a parasitic infection, may increase cervical cancer ...

New research has revealed that Schistosoma haematobium (S. haematobium), a parasitic infection affecting millions globally, ...

A newly presented study has uncovered troubling molecular changes in the cervix associated with a common parasitic infection, Schistosoma haematobium, and its standard treatment. The research, shared ...

New research suggests that an “often-overlooked” parasitic infection, already linked to bladder cancer, may also raise the risk of cervical cancer.

New research has revealed that Schistosoma haematobium (S. haematobium), a parasitic infection affecting millions globally, can trigger cancer-related gene activity in the cervical lining, with ...

New research has revealed that Schistosoma haematobium (S. haematobium), a parasitic infection affecting millions globally, can trigger cancer-related ...

A simple blood test may help determine whether your cervical cancer is responding to treatment or whether it has relapsed, ...

Cervical cancer is a type of cancer that originates in the cervix—the lower part of the uterus that connects to the vagina.

In a promising advancement for cancer care, doctors at AIIMS Delhi have developed a new blood test that could assist in ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck ...